Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |